Cross-Sector entity
American Academy of Dermatology is most often covered alongside Alexa Friedman, which appears in 3 of these 3 stories. The clearest coverage concentration is consumer-trends: 1 of 3 stories, with the rest divided among 2 other categories. The tracked stories average 18 original sources each.
3 verified stories tracked
Last mentioned: Jun 14, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
American Academy of Dermatology is most often covered alongside Alexa Friedman, which appears in 3 of these 3 stories. The clearest coverage concentration is consumer-trends: 1 of 3 stories, with the rest divided among 2 other categories. The tracked stories average 18 original sources each. American Academy of Dermatology appears in 3 tracked Cross-Sector stories from June 14, 2026.
Computed from the 3 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering American Academy of Dermatology. Shared-story counts are live from our verified record — not editorial picks.
FDA approves bemotrizinol for OTC sunscreens
The FDA grants approval for the first new chemical UV filter in nearly 30 years, ending a long regulatory drought for U.S. sunscreen ingredients.
The FDA’s approval of bemotrizinol opens the door for U.S. sunscreen brands to offer more advanced, photostable formulas that have long been available in Europe and Asia. Retailers can expect a wave of product launches and a shift in consumer preferences toward this next-generation UV filter.
The FDA’s approval of bemotrizinol, a chemical UV filter already widely used in other countries, represents a long-awaited regulatory milestone for the dermatology and OTC pharmaceutical industry. The decision signals a potential shift in the agency's approach to new sunscreen actives, with implications for ongoing GRASE reviews and future formulations.
The FDA has approved bemotrizinol, a broad-spectrum UV filter used in Europe and Asia, marking the first new chemical sunscreen ingredient in the U.S. in nearly three decades. Dermatologists praise its photostability and dual protection, which could improve skin cancer prevention and reduce irritation associated with avobenzone.
Source: houstonpublicmedia.org · iowapublicradio.org
